The Center for Hematologic Oncology provides specialized care for patients with all types of blood cancers, including leukemia, lymphoma, chronic lymphocytic leukemia, multiple myeloma, and Waldenström's macroglobulinemia, and myelodysplasia. We develop personalized, comprehensive treatment plans patients, offering the latest therapies as well as supportive resources. Through the Center, we offer more than 100 clinical trials exploring new approaches for newly-diagnosed and relapsed/refractory disease.
The Center includes our Stem Cell Transplantation and Cellular Therapies programs – both among the largest and most experienced in the world. Our stem cell transplant outcomes consistently exceed the expected outcomes as established by the Center for International Blood and Marrow Transplant Research (CIBMTR). Our Cellular Therapies program offers all commercial CAR T-cell therapies and many clinical trials of emerging cell therapies.
Featured Content |view more
